Femasys Inc.: Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control
Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive ...
Novo Nordisk's new CagriSema obesity drug trial to begin on Feb. 10, clinicaltrials.gov entry shows
Novo Nordisk will begin a new late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10, according to a entry.
Granules India Limited receives final approval from USFDA for its new drug
Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and ...
Prince Harry's visa lawsuit set for first court hearing under Donald Trump administration: Can he no longer stay in the US?
Prince Harry's visa status in the US faces scrutiny under the Trump administration. Judge Carl J. Nichols has ordered court hearings over allegations ...
Natco Pharma gets nod for generic Everolimus tablets
The approval is for the Abbreviated New Drug Application (ANDA) for Everolimus tablets for oral suspension (TFOS) of ...
BioPharma Dive16h
Enhertu, with new OK, set to supplant chemo in HER2-low breast cancer
The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...
Judge grants extradition of alleged drug smuggler Hussein Chamas
The accused drug smuggler is to be extradited to NSW after he was arrested on a yacht on Australia Day allegedly trying to ...